Toyama, Japan

Satoshi Ono

This inventor holds 21 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents, primarily in Medicinal Chemistry. Top assignee: Toyama Chemical Co., Ltd.. Active years: 1987-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Satoshi Ono. Retrieved from https://idiyas.com/inventor/satoshi-ono

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 95.2



Average Co-Inventor Count = 4.6

ph-index = 8

Forward Citations = 253(Granted Patents)


Company Filing History:


Years Active: 1987-2011

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Medicinal Compositions
Nerve Growth Factors
Diketopiperazine Derivatives
Brain Function Enhancement
Cerebral Remedies
Hair Growth Processes
Vasodilating Agents
Platelet Aggregation Inhibitors
Ethylene Glycol Derivatives
Nerve Degeneration Treatments
21 patents (USPTO):Explore Patents

Title: Innovations in Brain Function by Satoshi Ono

Introduction: Satoshi Ono, an accomplished inventor based in Toyama, Japan, has made significant contributions to the field of medicinal compositions aimed at improving brain function. With a remarkable portfolio of 21 patents to his name, Ono continues to push the boundaries of innovation in neuroscience.

Latest Patents: Among his latest innovations, Ono has developed medicinal compositions that enhance brain function through a unique alkyl ether derivative. This compound exhibits synergistically improved anti-hypoxic activity when paired with a substance that inhibits acetylcholine esterase activity. The implications of this invention are profound, as it offers potential treatments for conditions such as cerebrovascular dementia, senile dementia, Alzheimer's disease, and various forms of memory impairment linked to neuronal death.

Career Highlights: Throughout his career at Toyama Chemical Co., Ltd., Satoshi Ono has distinguished himself as a leader in the pharmaceutical industry. His focus on developing novel compositions has placed him at the forefront of research aimed at addressing cognitive dysfunction and enhancing cerebral health.

Collaborations: Ono has collaborated with notable colleagues, including Hirokazu Narita and Mutsuko Maekawa. Together, they have engaged in groundbreaking research that combines their expertise to advance the understanding of brain function and remediate its impairments.

Conclusion: Satoshi Ono remains a prominent figure in the field of medicinal chemistry, with his innovations providing hope for the treatment of complex neurological disorders. His commitment to research and collaboration with peers highlights the importance of innovation in improving overall brain health and function.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…